Siu Wing Fung Alfred
Siu Wing Fung Alfred, CHAIR, CEO, reported a transaction classified as grant at NewGenIvf Group Ltd involving 272140.000000 shares for an estimated $0.00. Reported holdings after the transaction were 345787.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 17, 2026
- Filing date
- Aug 18, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
NIVF price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001213900-26-091209 Stock Options (Right to Buy)
- Transaction date
- Aug 17, 2026 Filed Aug 18, 2026, 08:01 PM · 1d delay
- Shares
- 272,140 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 345,787 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chairman & CEO
- F1
Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and th…
0 other transactions
0 recent txs